Posted by Michael Wonder on 26 Jul 2016
ICER release final reports on obeticholic acid for treatment of PBC and NASH
26 July 2016 - The ICER has released two final reports, the first titled Obeticholic Acid for the Treatment of Primary Biliary Cholangitis: Comparative Clinical Effectiveness, Value, and Value-Based Price Benchmarks, and the second titled Obeticholic Acid for the Treatment of Nonalcoholic Steatohepatitis: Comparative Clinical Effectiveness and Value.
The final reports, which review the comparative clinical effectiveness and value of obeticholic acid for treatment of these two liver diseases, incorporate a summary of votes taken on the evidence during a public meeting of the New England Comparative Effectiveness Public Advisory Council, as well as key policy recommendations stemming from discussion with a panel of experts during the meeting.
